Ardelyx (ARDX) Tax Provisions (2013 - 2026)

Ardelyx (ARDX) reported Tax Provisions of $8000.0 for Q1 2026, down 99.07% on a YoY basis from $859000.0 in Q1 2025, and up 14.29% quarter-over-quarter from $7000.0 in Q4 2025.

Ardelyx (ARDX) Tax Provisions (2013 - 2026) Analysis & Trends

Ardelyx has reported Tax Provisions for 13 years, with the latest figure at $8000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Tax Provisions fell 99.07% year-over-year to $8000.0; the trailing twelve-month figure through Mar 2026 stood at $118000.0 (down 88.25% YoY), and the FY2025 full-year result was $969000.0, up 264.29% from the prior year.
  • Tax Provisions for Q1 2026 stood at $8000.0, up from $7000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $859000.0 in Q1 2025, with the low at $1000.0 in Q2 2025.
  • Historically, Tax Provisions has averaged $128428.6 across 5 years, with a median of $39000.0 in 2024.
  • Annual changes were most pronounced in 2024 — Tax Provisions soared 764.29% — and 2026, when it sank 99.07%.
  • Ardelyx's Tax Provisions stood at $6000.0 in 2022, then jumped by 5450.0% to $333000.0 in 2023, then sank by 89.49% to $35000.0 in 2024, then tumbled by 80.0% to $7000.0 in 2025, then increased by 14.29% to $8000.0 in 2026.
  • The last three Tax Provisions figures came in at $8000.0 (Q1 2026), $7000.0 (Q4 2025), and $102000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -11.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 216,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -859,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 221.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 8,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 8,000.00
Dec 31, 2025 7,000.00
Sep 30, 2025 102,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 859,000.00
Dec 31, 2024 35,000.00
Sep 30, 2024 43,000.00
Jun 30, 2024 67,000.00
Mar 31, 2024 121,000.00
Dec 31, 2023 333,000.00
Sep 30, 2023 200,000.00
Mar 31, 2023 14,000.00
Jun 30, 2022 6,000.00
Mar 31, 2022 2,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 2,000.00
Mar 31, 2021 1,000.00
Dec 31, 2020 2,000.00
Sep 30, 2019 301,000.00
Mar 31, 2019 2,000.00